Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial
Crossref DOI link: https://doi.org/10.2337/dc15-1025
Published Online: 2015-08-17
Published Print: 2016-02-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Idorn, Thomas
Knop, Filip K.
Jørgensen, Morten B.
Jensen, Tonny
Resuli, Marsela
Hansen, Pernille M.
Christensen, Karl B.
Holst, Jens J.
Hornum, Mads
Feldt-Rasmussen, Bo
Funding for this research was provided by:
Novo Nordisk
Version of Record valid from 2016-08-01